Form N-VP/A NATIONAL SECURITY VARIAB
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil slips but stays near six-month highs on Saudi attacks
- BofA flags further downside risk for stocks, yields and dollar
Tweet
Share
E-mailNScore Series of Variable Annuities
National Security Life and Annuity Company
National Security Variable Account N
Supplement dated November 25, 2024
to the Prospectuses date May 1, 2019 and
the Update Notices dated April 30, 2024
The following supplements the prospectuses dated May 1, 2019, as may be previously supplemented, and the update notices dated April 30, 2024, as previously supplemented. Please read this supplement in conjunction with your prospectus and update notice and retain it for future reference.
Appendix A – Funds Available Under the Contract
On or about November 25, 2024, the portfolios listed below removed their subadvisers, updated their fees, and changed their names. Appendix A is revised, effective upon such changes:
| Type/ Investment Objective |
Fund and Adviser/Subadviser |
Current Expenses |
Average Annual Total Returns (as of 12/31/23) | ||
| 1 year | 5 year | 10 year | |||
|
Allocation
|
AVIP Constellation Dynamic Risk Balanced Portfolio
Adviser: Constellation Investments, Inc. |
0.88% | 12.90% | 8.97% | N/A |
| Allocation |
AVIP Constellation Managed Risk Balanced Portfolio
Adviser: Constellation Investments, Inc. |
0.65% | 13.89% | N/A | N/A |
| Allocation |
AVIP Constellation Managed Risk Moderate Growth Portfolio
Adviser: Constellation Investments, Inc. |
0.65% | 16.15% | N/A | N/A |
| Allocation |
AVIP Constellation Managed Risk Growth Portfolio Adviser: Constellation Investments, Inc. |
0.66% | 19.62% | N/A | N/A |
Any changes made in Appendix A above are incorporated throughout your documents.
1
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Artelo Biosciences to Showcase First-in-Human FABP5 Inhibitor ART26.12 as a Novel Approach to Pain Treatment at IASP 2026 World Congress on Pain
- Homivo Launches Plain English Property Search For Homes And Land In Northern Scotland
- NevGold Appoints Sean Waller to Board of Directors; Key Addition of Project Development and Mineral Process Engineering Expertise
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
